Table 2. List of papers reporting relevant outcomes for early revision.
| Authors (publ year) | year range | Region/ registry (Patient volume) | Early Rev cut-off | overall Rev Rate |
Associations-indications,
Param. under study |
|---|---|---|---|---|---|
| Silijander et al (2020) | 2015-2017 | Michigan AR (5000 THA) | 3 mo | ant:0.9% sup: 1.5% post:0.4% |
surgical approach vs age, BMI, sex, ASA, smoking, DM rev. reason: fracture, instability, infection, loosening Length of stay, readmission, home discharge, etc |
| Rhee et al (2017) | 2000-2014 | Nova scotia database (10000 THA) |
3 mo,
1y |
0.9% and 1.6% | overall revision, death and infection rates vs DM, liver and hearth disease, age, blood transf. |
| Rhee et al (2017) | 2000-2014 | Nova scotia (17000 TKA) |
3 mo
1y |
0.5% and 1.4% | |
| Ferguson et al (2019) | 2008-16 1996-16 | Geneva AR (5000) Swedish AR (122k) |
3 mo
5y |
incidence of rev=0.6 to 2.3% | Revision and re-operation vs. op. year, ASA score indication: dislocation, infection, fracture, loosening |
| Cnudde et al. (1997) | 1999-2012 | Swedish AR SHAR (190k) |
1 mo
3 mo 2y |
2y Rev.Rate 3% to 1.5% decrease | Early rev. vs. primary oper. year Reoper., revision, mortality rate Indication for operation; Fixation, bearing, PROM, QoL, pain |
| De la Torre et al. (2020) | 2005-2016 | catalan AR (18000) |
1y
5y |
ca 2.5% | revision risk vs. multiple comorbidity: obesity, liver disease, anemia, vascular disease, cancer psychoses. |
| De la Torre et al. (2020) | 2005-2016 | catalan AR (49000) |
1y
5y |
ca 3.6% | |
| Singh et al (2016) | 2005-2011 | Winnipeg Reg. Health Authority CAN (12000) |
2y
2-10y >10y |
4% (2005) to 2.1% (2011) | ER vs. primary oper. year infection, loosening, instability, fracture Infection, instability, Stiffness, Patella maltracking |
| Singh et al (2016) | 2005-2011 | Winnipeg Reg. Health Authority CAN (18000) |
2y
2-10y >10y |
3% (2005) to 1.3% (2011) | |
| Kee et al. (2017) | 2015-6 | Arkansas (57000) | 2y | incidence of patol. >1 mod.RF=40% | modifiable Risks factors for sept/asept Revision BMI>40, smoking, dental health, HbA1c>8 |
| Kee et al. (2017) | 2015-6 | Arkansas (71000) | 2y | incidence of patol. >1 mod.RF=44% | |
| van Loon et al. (2021) | 2007-19 | LROI - netherl. Arthr Reg. (33000) | 2y | Rev risk for asept. loosening | Bearing type CoC vs CoP |
| Wyles et al. (2014) | >2000 | metaanalysis | 2y | same short term rev. risk | Bearing Type (CoC /CoP/ MoM/ MoP) Pat <65y old |
| Thien et al. (2014) | 1995-2009 | NARA Scandinavian Arthr. Reg. (300k cem 111k uncem stems) |
6 mo (2y) | RR uncem =0.42% - (0.47%) RR cem.=0.04% - (0.07%) |
cem vs uncem stems; age, sex, implant design, preop. diagnosis ER vs. primary oper. year |
| Bottle et al (2019) | 2009-14 | UK nat. administr data (315k) | 3y | RR=2.1% | -multiple emerg. admission, -comorbidities -resurfacing vs THA |
| Bottle et al (2019) | 2009-14 | UK nat. hosp. administr data (347k) | 3y | RR=2.2% | |
| Roof et al (2022) | 2014-2019 | NYU Langone hospital (167k) | 5y | 33% potentially avoidable complications | "avoidable" revisions: instability, intraop fracture, metal allergy, maltracking |
| Dy et al. (2013) | 1997-2005 | NY and CA statewide data (300k) | 5y; 9y | 4% and 8.9% | hazard ratio vs sex, age, insurance type, education, pop. Density |
| Duman et al. (2021) | 2005-2011 | 396 THA Revisions | <2y, 2-5, 5-10y | ||
| Quinlan et al (2020) | private insurance database US (ca 400 Pat. Peripr Joint infection) | OR 5,6 for PJI in 1 y OR 4,8 for PJI in 2y |
Early aseptic Revision second hit facilitating Periprost. joint infection | ||
| Urish et al. (2020) | 2020 | nationwide readmission database up to 2013 (21000) |
3 mo
1 y |
Revision and reoperation Periprost. joint infection 62% of revisions |